SCHEMBL20937652

SCHEMBL20937652

COc1c(C)cnc(CN(C(=O)OC(C)(C)C)c2ccc(F)cc2)c1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGXT P21549 1/20 0.39
HDAC1 Q13547 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
ATP4A P20648 4/20 0.37
ATP4B P51164 4/20 0.37
FTO Q9C0B1 1/20 0.36
POLQ O75417 2/20 0.35
SSTR4 P31391 1/20 0.34
KMT2A Q03164 4/20 0.33
WDR5 P61964 3/20 0.33
ATP1A1 P05023 2/20 0.33
ATP1B1 P05026 2/20 0.33
ATP1A3 P13637 2/20 0.33
ATP1B2 P14415 2/20 0.33
ATP1A2 P50993 2/20 0.33
ATP1B3 P54709 2/20 0.33
FXYD2 P54710 2/20 0.33
ATP1A4 Q13733 2/20 0.33
DDAH1 O94760 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19512934 0.91 AGXT (0.40) AGXTHDAC1HDAC8HDAC6ATP4A
SCHEMBL19513028 0.90 AGXT (0.40) AGXTATP4AATP4BFTOKMT2A
SCHEMBL19512668 0.89 AGXT (0.40) AGXTHDAC1HDAC8HDAC6ATP4A
SCHEMBL19512670 0.89 HDAC1 (0.39) AGXTHDAC1HDAC8HDAC6ATP4A
SCHEMBL20936992 0.88 HDAC1 (0.51) AGXTHDAC1HDAC8HDAC6ATP4A
SCHEMBL19513144 0.88 HDAC1 (0.39) AGXTHDAC1HDAC8HDAC6ATP4A
SCHEMBL20914499 0.85 AGXT (0.43) AGXTATP4AATP4BFTOPOLQ
SCHEMBL20937144 0.84 HDAC1 (0.38) AGXTHDAC1HDAC8HDAC6ATP4A
SCHEMBL30285057 0.84 HDAC1 (0.38) AGXTHDAC1HDAC8HDAC6ATP4A
SCHEMBL19512701 0.83 HDAC1 (0.41) AGXTHDAC1HDAC8HDAC6POLQ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10696635-B2 Versatile ligand for palladium-catalyzed meta-C—H functionalizations of aromatic substrates THE SCRIPPS RESEARCH INSTITUTE (US) 2020-06-30 US disclosed
US-20190119212-A1 A VERSATILE LIGAND FOR PALLADIUM-CATALYZED META-C-H FUNCTIONALIZATIONS THE SCRIPPS RESEARCH INSTITUTE 2019-04-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190119212-A1 A VERSATILE LIGAND FOR PALLADIUM-CATALYZED META-C-H FUNCTIONALIZATIONS AHR, PAH, DOHH AGXT 2288/4885HDAC1 1011/4885HDAC8 1139/4885
US-10696635-B2 Versatile ligand for palladium-catalyzed meta-C—H functionalizations of aromatic substrates PAH, AHR, DDC AGXT 2246/4885HDAC1 1111/4885HDAC8 1817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.